ESG-screening and factor-risk-adjusted performance: the concentration level of screening does matter
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Sustainable Finance and Investment"
DOI: 10.1080/20430795.2020.1837501
Abstract: Constructing ESG-screened portfolios aims to reduce the aggregate ESG-risk at the portfolio level by excluding low ESG-score constituents from the selection universe. But ESG-screening imposes limi... read more here.
Keywords: esg; screening factor; factor risk; level ... See more keywords
A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale.
Sign Up to like & getrecommendations! Published in 2023 at "Blood advances"
DOI: 10.1182/bloodadvances.2022009507
Abstract: In patients with non-Hodgkin lymphoma (NHL), formal comorbidity assessment is recommended but is rarely done in routine practice. A simple, validated measure of comorbidities that standardized their assessment could improve adherence to guidelines. We previously… read more here.
Keywords: hodgkin lymphoma; non hodgkin; lymphoma; factor risk ... See more keywords